Long-Term Use of Benzodiazepines and Benzodiazepine Related Drugs
Identifying Attributes
Care Settings
Primary Care
Country
Organisation for Economic Co-operation and Development
Publishing Organisation
Organisation for Economic Co-operation and Development (OECD): Healthcare Quality and Outcomes (HCQO) indicators - Primary Care - Prescribing Indicators
Type of Quality Indicator
Process
IOM Quality Dimension
Safety
Domain
Medications and Medication Management
Defining Attributes
Definition
Long-term use of benzodiazepines and benzodiazepine related drugs in people aged 65 years and over ( > 365 defined daily dose in one year)
Numerator
Number of individuals ≥ 65 years of age on 1 January in the prescribing database with > 365 DDDs of benzodiazepines (N05BA or N05CD or N05CF or N03AE01) prescribed in the year.
Denominator
Number of individuals ≥ 65 years of age on 1 January in the prescribing database. If prescribing database does not report DDD, derive indicator using > 365 days of benzodiazepines per year
Exclusions
Use of Risk Adjustment
No
Risk Adjustments
Stratifications
Collection and Reporting Attributes
Type of Data Collection
Administrative data
Data Collection Methods
OECD
Frequency of Data Collection
Annually
Frequency of Data Collection in Days
365
Reporting Methods
Reporting Frequency
Annually
Reporting Frequency in Days
365
Indicator Has Recommended Targets
No
Source and Reference Attributes
Evidence Source
Technical Specifications
Link to Measurement Tools
Quality Indicator Confirmed to be Part of a Program Used to Monitor Quality and Safety of Care Among Older People at a Population-Level between 2012-2022
Yes
Assessed by the Australian Consortium for Aged Care Collaborators as Generally Containing Good Properties (Importance and Scientific Acceptability)
No
Australian Consortium for Aged Care Endorsed
No
Identified by PHARMA-Care Project
No
Upload Date
02 December 2025
Contents
Actions
Date Modified 02 December 2025